Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Heisser

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Deutsches Arzteblatt International|December 24, 2021
Earlier Screening Colonoscopy in Men: Additional Screening Is Needed at Older AgesThomas Heisser, Tobias Möllers, Rafael Cardoso, et al.
JAMA Internal Medicine|January 17, 2023
Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening ColonoscopiesThomas Heisser, Jens Kretschmann, Bernd Hagen, et al.
Gastroenterology|August 11, 2020
Low Risk of Advanced Neoplasms for up to 20 Years After Negative Colonoscopy Result: Potential for Personalized Follow-up Screening IntervalsThomas Heisser, Feng Guo, Tobias Niedermaier, et al.
International Journal of Cancer|April 2, 2024
Indications of sustained delay of colorectal cancer diagnoses in Germany during the first 2 years of the COVID-19 pandemicHermann Brenner, Lisa Weber, Rafael Cardoso, et al.
Deutsches Arzteblatt International|June 28, 2021
Incidence and Mortality of Proximal and Distal Colorectal Cancer in Germany—Trends in the Era of Screening ColonoscopyRafael Cardoso, Anna Zhu, Feng Guo, et al.
Journal of the National Cancer Institute|October 30, 2025
Early-detection and prevention effects of screening sigmoidoscopy: evidence from randomized trials revisitedHermann Brenner, Tim Holland-Letz, Annette Kopp-Schneider, et al.
Deutsches Arzteblatt International|June 25, 2025
Fecal Occult Blood Tests for Colorectal Cancer Screening in Routine Medical Care: A Longitudinal Analysis From GermanyLeon Klimeck, Thomas Heisser, Beata Hennig, et al.
Cancer Communications (London, England)|June 5, 2023
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessmentTobias Niedermaier, Elizabeth Alwers, Xuechen Chen, et al.
Cancers|February 10, 2021
Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal CancersAnton Gies, Tobias Niedermaier, Laura Fiona Gruner, et al.
International Journal of Cancer|July 19, 2021
To what extent is male excess risk of advanced colorectal neoplasms explained by known risk factors? Results from a large German screening populationTobias Niedermaier, Thomas Heisser, Anton Gies, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Deutsches Arzteblatt International|December 24, 2021
Earlier Screening Colonoscopy in Men: Additional Screening Is Needed at Older AgesThomas Heisser, Tobias Möllers, Rafael Cardoso, et al.
JAMA Internal Medicine|January 17, 2023
Prevalence of Colorectal Neoplasia 10 or More Years After a Negative Screening Colonoscopy in 120 000 Repeated Screening ColonoscopiesThomas Heisser, Jens Kretschmann, Bernd Hagen, et al.
Gastroenterology|August 11, 2020
Low Risk of Advanced Neoplasms for up to 20 Years After Negative Colonoscopy Result: Potential for Personalized Follow-up Screening IntervalsThomas Heisser, Feng Guo, Tobias Niedermaier, et al.
International Journal of Cancer|April 2, 2024
Indications of sustained delay of colorectal cancer diagnoses in Germany during the first 2 years of the COVID-19 pandemicHermann Brenner, Lisa Weber, Rafael Cardoso, et al.
Deutsches Arzteblatt International|June 28, 2021
Incidence and Mortality of Proximal and Distal Colorectal Cancer in Germany—Trends in the Era of Screening ColonoscopyRafael Cardoso, Anna Zhu, Feng Guo, et al.
Journal of the National Cancer Institute|October 30, 2025
Early-detection and prevention effects of screening sigmoidoscopy: evidence from randomized trials revisitedHermann Brenner, Tim Holland-Letz, Annette Kopp-Schneider, et al.
Deutsches Arzteblatt International|June 25, 2025
Fecal Occult Blood Tests for Colorectal Cancer Screening in Routine Medical Care: A Longitudinal Analysis From GermanyLeon Klimeck, Thomas Heisser, Beata Hennig, et al.
Cancer Communications (London, England)|June 5, 2023
A single measurement of fecal hemoglobin concentration outperforms polygenic risk score in colorectal cancer risk assessmentTobias Niedermaier, Elizabeth Alwers, Xuechen Chen, et al.
Cancers|February 10, 2021
Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal CancersAnton Gies, Tobias Niedermaier, Laura Fiona Gruner, et al.
International Journal of Cancer|July 19, 2021
To what extent is male excess risk of advanced colorectal neoplasms explained by known risk factors? Results from a large German screening populationTobias Niedermaier, Thomas Heisser, Anton Gies, et al.
Pageof 6